Neovacs S.A. (ALNEV.PA)

EUR 0.02

(-3.52%)

Operating Expenses Summary of Neovacs S.A.

  • Neovacs S.A.'s latest annual operating expenses in 2023 was 10.34 Million EUR , down -94.88% from previous year.
  • Neovacs S.A.'s latest quarterly operating expenses in 2024 Q2 was 592.92 Thousand EUR , down 0.0% from previous quarter.
  • Neovacs S.A. reported a annual operating expenses of 2.99 Million EUR in annual operating expenses 2022, down -30.71% from previous year.
  • Neovacs S.A. reported a annual operating expenses of 4.32 Million EUR in annual operating expenses 2021, up 154.53% from previous year.
  • Neovacs S.A. reported a quarterly operating expenses of 68.43 Thousand EUR for 2023 Q2, down 0.0% from previous quarter.
  • Neovacs S.A. reported a quarterly operating expenses of 153.19 Thousand EUR for 2023 FY, down -94.88% from previous quarter.

Annual Operating Expenses Chart of Neovacs S.A. (2023 - 2009)

Created with Highcharts 11.1.0YearsOperating Expenses2009201020112012201320142015201620172018201920202021202220230 EUR5000000 EUR10000000 EUR15000000 EUR20000000 EUR25000000 EUR

Historical Annual Operating Expenses of Neovacs S.A. (2023 - 2009)

Year Operating Expenses Operating Expenses Growth
2023 10.34 Million EUR -94.88%
2022 2.99 Million EUR -30.71%
2021 4.32 Million EUR 154.53%
2020 1.69 Million EUR -79.33%
2019 8.21 Million EUR -22.45%
2018 10.59 Million EUR -44.25%
2017 18.99 Million EUR 551.19%
2016 2.91 Million EUR 98.02%
2015 1.47 Million EUR -27.42%
2014 2.02 Million EUR -72.49%
2013 7.37 Million EUR -7.53%
2012 7.98 Million EUR 274.08%
2011 2.13 Million EUR -18.97%
2010 2.63 Million EUR 38.65%
2009 1.89 Million EUR 0.0%

Peer Operating Expenses Comparison of Neovacs S.A.

Name Operating Expenses Operating Expenses Difference
ABIONYX Pharma SA 4.17 Million EUR -147.631%
ABIVAX Société Anonyme 127.37 Million EUR 91.88%
Adocia SA 15.62 Million EUR 33.818%
Aelis Farma SA 18.81 Million EUR 45.037%
Biophytis S.A. 14.33 Million EUR 27.834%
Advicenne S.A. 8.21 Million EUR -25.91%
genOway Société anonyme 16.73 Million EUR 38.204%
IntegraGen SA 5.35 Million EUR -93.247%
Medesis Pharma S.A. 1.56 Million EUR -561.11%
NFL Biosciences SA 4.37 Million EUR -136.459%
Plant Advanced Technologies SA 2.76 Million EUR -274.109%
Quantum Genomics Société Anonyme 1.71 Million EUR -502.081%
Sensorion SA 27.05 Million EUR 61.767%
Theranexus Société Anonyme 3 Million EUR -244.213%
TME Pharma N.V. 5.49 Million EUR -88.167%
Valbiotis SA 9.86 Million EUR -4.808%
TheraVet SA 1.64 Million EUR -529.05%
Valerio Therapeutics Société anonyme 20.32 Million EUR 49.097%
DBV Technologies S.A. 89.4 Million EUR 88.431%
Genfit S.A. 54.8 Million EUR 81.126%
GeNeuro SA 14.35 Million EUR 27.956%
Innate Pharma S.A. 64.57 Million EUR 83.981%
Inventiva S.A. 120.18 Million EUR 91.394%
MaaT Pharma SA 21.59 Million EUR 52.109%
MedinCell S.A. 32.92 Million EUR 68.582%
Nanobiotix S.A. 58.92 Million EUR 82.447%
OSE Immunotherapeutics SA 23.58 Million EUR 56.151%
Poxel S.A. 28.76 Million EUR 64.041%
GenSight Biologics S.A. 32.66 Million EUR 68.33%
Transgene SA 31.23 Million EUR 66.881%
Valneva SE 134.92 Million EUR 92.334%